News

In May, Allergy & Anaphylaxis Australia led Food Allergy Week 2026 to help raise awareness of food allergy and anaphylaxis across Australia. Australia continues to have one of the highest rates of food allergy and hospital anaphylaxis admissions in the…

A series of food recalls issued in March and early April 2026 triggered by undeclared allergens has again highlighted the ongoing challenges of allergen management in food manufacturing and labelling.   According to official recall notices published by food regulators,…

From egg‑free mayonnaise to yeast‑derived milk, Japanese food companies are looking to reshape how allergen‑free products are positioned — not as compromises, but as everyday choices with broader appeal.  Japanese media outlet Japan Forward has reported on this trend alongside statistics on food allergy in Japan, noting that despite growing availability, allergen‑free foods…

The prescription-only peanut allergy treatment Palforzia® will be discontinued on 31 July 2026, according to its manufacturer, Stallergenes Greer. The therapy received approval from the U.S. Food and Drug Administration (FDA) in 2020.  Palforzia is the only oral immunotherapy approved by the FDA for the treatment…

A recent study published in the Journal of Food Protection examined how, when reused, high levels of cashew allergens in frying and roasting oil can transfer to other foods. This sheds light on a potentially overlooked pathway for allergen exposure.…

In February 2026, the U.S. Food and Drug Administration (FDA) convened a virtual public meeting and listening session on food allergen thresholds and their potential applications, signalling a major step forward in how allergen risks may be assessed and managed…